Pfizer Vaccine Candidate Gains FDA Support for RSV in Older Adults
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee
Pfizer Vaccine Candidate Gains FDA Support for RSV in Older Adults
